Adult T-cell lymphoma/leukemia (HTLV-1-associated) in relapse is a hematological malignancy caused by the human T-cell lymphotropic virus type 1 (HTLV-1). This condition is clinically significant due to its aggressive nature and poor prognosis. Accurate coding with ICD-10 Code C91.52 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat affected patients.
ICD-10 Code C91.52 represents Adult T-cell lymphoma/leukemia (HTLV-1-associated) in relapse, indicating a recurrence of this aggressive malignancy. This code should be used when documenting cases where the disease has returned after a period of remission, ensuring accurate representation of the patient's clinical status for billing and treatment planning.
Adult T-cell lymphoma/leukemia (HTLV-1-associated) in relapse is characterized by the re-emergence of malignant T-cells following treatment. The condition is caused by infection with HTLV-1, leading to uncontrolled proliferation of T-lymphocytes. Prompt medical attention is critical due to its aggressive progression and potential complications.
ICD-10 Code C91.52 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. This code is relevant in both acute and chronic care settings, facilitating comprehensive documentation of the patient's clinical status and guiding appropriate management strategies.
In SOAP notes, ICD-10 Code C91.52 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of relapse. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Management of Adult T-cell lymphoma/leukemia (HTLV-1-associated) in relapse requires urgent intervention, often necessitating hospitalization for intensive treatment.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C91.52 is crucial for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 36415 | Collection of venous blood by venipuncture. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
Common Questions About Using ICD-10 Code C91.52 for Adult T-cell lymphoma/leukemia (HTLV-1-assoc), in relapse
What are the common symptoms of Adult T-cell lymphoma/leukemia in relapse?
Common symptoms include recurrent lymphadenopathy, fatigue, weight loss, fever, and night sweats. Patients may also experience skin lesions and hypercalcemia.
How is Adult T-cell lymphoma/leukemia treated during relapse?
Treatment typically involves chemotherapy regimens tailored for relapsed cases, along with supportive care to manage symptoms and complications.
When should ICD-10 Code C91.52 be used?
This code should be used when documenting a relapse of Adult T-cell lymphoma/leukemia after a period of remission, ensuring accurate representation of the patient's clinical status.
What is the prognosis for patients with Adult T-cell lymphoma/leukemia in relapse?
The prognosis is generally poor due to the aggressive nature of the disease and the challenges associated with treatment resistance.
Clinical Notes
SOAP notes
DAP notes
AI medical notes